Insulin resistance, hyperleptinemia and endothelial dysfunction in coronary restenosis

Current Opinion in Pharmacology

Volumn 5, Issue 2 SPEC. ISS., 2005, Pages 160-164

  Piatti, PierMarco M ^a   Monti, Lucilla D ^a  

^a FC San Raffaele del Monte Tabor   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ENDOTHELIN 1; INSULIN; INSULIN SENSITIZING AGENT; LEPTIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; TROGLITAZONE;

ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CLINICAL TRIAL; CORONARY STENT; DRUG TARGETING; ENDOTHELIUM CELL; ENDOTHELIUM LESION; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERLEPTINEMIA; IN-STENT RESTENOSIS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTENOSIS; RISK FACTOR; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 15044355254     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.10.004     Document Type: Review

References (34)

1. A.J. Scheen F. Warzee Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries Diabetes Care 27 2004 1840-1841
2. M.L. Correia W.G. Haynes Leptin, obesity and cardiovascular disease Curr Opin Nephrol Hypertens 13 2004 215-223
3. K.H. Mak D.P. Faxon Clinical studies on coronary revascularization in patients with type 2 diabetes Eur Heart J 24 2003 1087-1103
4. J.H. Fuller M.J. Shipley G. Rose R.J. Jarret H. Kween Coronary-heart-disease risk and impaired glucose tolerance: The Whitehall study Lancet 1 1980 1373-1376
5. T. Takagi T. Akasaka A. Yamamuro Y. Honda T. Hozumi S. Morioka K. Yoshida Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation: Intravascular ultrasound studies J Diabetes Complications 16 2002 50-55
6. P.M. Piatti C. Di Mario L.D. Monti G. Fragasso F. Sgura A. Caumo E. Setola P. Lucotti E. Galluccio C. Ronchi et al. Association of insulin resistance, hyperinsulinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting Circulation 108 2003 2074-2081
7. T. Takagi K. Yoshida T. Akasaka S. Kaji T. Kawamoto Y. Honda A. Yamamuro T. Hozumi S. Morioka Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in non diabetic patients J Am Coll Cardiol 36 2000 731-738
8. E. Babalik T. Gurmen L. Orhan H. Bulur M. Gulbaran M. Ersanli S. Ozturk Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients Catheter Cardiovasc Interv 58 2003 306-312
9. S. Zhang Y. Yang B.C. Kone J.C. Allen A.M. Kahn Insulin-stimulated cyclic guanosine monophosphate inhibits vascular smooth muscle cell migration by inhibiting Ca/calmodulin-dependent protein kinase II Circulation 107 2003 1539-1544
10. M.P. Trovati P. Massucco L. Mattiello F. Cavalot E. Mularoni A. Hahn G. Anfossi Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: A mechanism potentially involved in insulin-induced modulation of vascular tone Diabetologia 38 1995 936-941
11. P.M. Piatti G. Fragasso L.D. Monti E. Setola P. Lucotti I. Fermo R. Paroni E. Galluccio G. Pozza S. Chierchia A. Margonato Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: Correlation with asymmetric dimethylarginine levels Circulation 107 2003 429-436
12. K. Cusi K. Maezono A. Osman M. Pendergrass M.E. Patti T. Pratipanawatr R.A. De Fronzo C.R. Kahn L.J. Mandarino Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle J Clin Invest 105 2000 311-320
13. T. Takagi T. Akasaka A. Yamamuro Y. Honda T. Hozumi S. Morioka K. Yoshida Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: A serial intravascular study J Am Coll Cardiol 36 2000 1529-1535
14. T. Takagi A. Yamamuro K. Tamita K. Yamabe M. Katayama S. Mizoguchi M. Ibuki T. Tani K. Tanabe K. Nagai et al. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: An intravascular ultrasound scanning study Am Heart J 146 2003 E5
15. D. Choi S.K. Kim S.H. Choi Y.G. Ko C.W. Ahn Y. Jang S.K. Lim H.C. Lee B.S. Cha Preventive effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes Diabetes Care 27 2004 2654-2660
16. P.M. Vanhoutte The endothelium: Modulator of vascular smooth muscle tone N Engl J Med 319 1988 512-513
17. G. Zeng F.H. Nystrom L.V. Ravichandran L.N. Cong M. Kirby H. Mostowski M.J. Quon Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells Circulation 101 2000 1539-1545
18. F.J. Oliver G. de la Rubia E.P. Feener M.E. Lee M.R. Loeken T. Shiba T. Quertermous G.L. King Stimulation of endothelin-1 gene expression by insulin in endothelial cells J Biol Chem 266 1991 23251-23256
19. Y. Kawanabe N. Hashimoto T. Masaki Involvements of voltage-independent CA2+ channels and phosphoinositide 3-kinase in endothelin-1 induced PYK2 tyrosine phosphorilation Mol Pharmacol 63 2003 808-813
20. T.C. Wu Y.H. Chen J.W. Chen L.C. Chen S.J. Lin P.Y. Ding S. Wang M.S. Chang Impaired forearm reactive hyperemia is related to late restenosis after coronary stenting Am J Cardiol 85 2000 1071-1076
21. V. Schachinger M.B. Britten A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899-1906
22. U. Ikeda K. Yamamoto Y. Maeda M. Shimpo T. Kanbe K. Shimada Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells Hypertension 29 1997 65-69
23. J.P. Cooke R.K. Oka Does leptin cause vascular disease? Circulation 106 2002 1904-1905
24. P. Veermersch Z. Nong E. Stabile O. Varenne H. Gillijns M. Pellens N. Van Pelt M. Hoylaerts I. De Scheerder D. Collen S. Janssens L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism Arterioscler Thromb Vasc Biol 21 2001 1604-1609
25. T. Le Tourneau E. Van Belle D. Corseaux B. Vallet G. Lebuffe B. Dupuis J.M. Lablance E. McFadden C. Bauters M.E. Bertrand Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: Effects on neointimal hyperplasia and vascular remodeling J Am Coll Cardiol 33 1999 876-882
26. T. Suzuki M. Hayase K. Hibi H. Hosokawa K. Yokoya P.J. Fitzgerald P.G. Yock J.P. Cooke T. Suzuki A.C. Yeung Effect of local delivery of L-arginine on in-stent restenosis in humans Am J Cardiol 89 2002 363-367
27. J. George S.B. Shmuel A. Roth I. Herz S. Izraelov V. Deutsch G. Keren H. Miller L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty Atherosclerosis 174 2004 323-327
28. A.M. Wallace A.D. Mc Mahon C.J. Packard A. Kelly J. Shepherd A. Gaw N. Sattar Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS) Circulation 104 2001 3052-3056
29. M.P. Reilly N. Iqbal M. Schutta M.L. Wolfe M. Scally A.R. Localio D.J. Rader S.E. Kimmel Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes J Clin Endocrinol Metab 89 2004 3872-3878
30. F. Parhami Y. Tintut A. Ballard A.M. Fogelman L.L. Demer Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin Circ Res 88 2001 954-960
31. S.M. Kang H.M. Know B.K. Hong D. Kim I.J. Kim E.Y. Choi Y. Jang H.S. Kim M.S. Kim H.C. Know Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: Potential role in intima neovascularization Yonsei Med J 41 2000 68-75
32. P.F. Bodari R.J. Westrick K.J. Wickenheiser Y. Shen D.T. Eitzman Effect of leptin on arterial thrombosis following vascular injury in mice JAMA 287 2002 1706-1709
33. H.J. Park H.M. Kwon H.J. Lim B.K. Hong J.Y. Lee B.E. Park Y. Jang S.Y. Cho H.S. Kim Potential role of leptin in angiogenesis: Leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro Exp Mol Med 33 2001 95-102
34. N. Werner G. Nickening From fat fighter to risk factor. The zigzag trek of leptin Arterioscler Thromb Vasc Biol 24 2004 7-9